DAN MEDICA SOUTH LIMITEDActive

Company number 04373372Private limited companyIncorporated 2002

Key figures

£56,594-37.6%
Net assets 2024/25
+25.2%
Average annual growth 2020/21–2024/25
025 k50 k75 k100 k2020/212021/222022/232023/242024/25

Like most small UK companies, DAN MEDICA SOUTH LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k150 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand16,4777,30031,65636,11331,984
Total assets63,64673,93299,543128,20286,443
Total liabilities39,77731,87844,03736,68629,022
Net assets / total equity23,03041,42554,98990,67556,594
Average number of employees22222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: DAN MEDICA SOUTH LIMITED

Company

DAN MEDICA SOUTH LIMITED is a private limited company registered with Companies House under company number 04373372. It was incorporated on 13 Feb 2002. Its status is active. The registered office is in Eastbourne (BN21). Its nature of business (SIC 2007) is manufacture of medical and dental instruments and supplies (32500).

Accounts

The latest accounts in the database are for 2024/25 (period ending 28 Feb 2025); the company files small company accounts (filleted). Net assets were £56,594, down 37.6% on the previous year. Cash at bank and in hand was £31,984. Total assets were £86,443 and total liabilities £29,022. The company had an average of 2 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

2 persons with significant control are registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 27 Feb 2027.